BMO Capital Markets views recent declines in Chemours Co. (NYSE:CC) and Solstice Inc. as buying opportunities. The EPA reportedly plans to extend the deadline for grocers to transition refrigerants.
Chemours stock fell 10.1% over the past week but is up 116% over the past year. Shares trade at $21.49 with a market cap of $3.23 billion.
The EPA will extend the HFC to HFO transition deadline from 2027 to 2032. Both companies produce legacy HFCs and next-generation HFOs.
BMO estimates a low single-digit sales impact for Chemours and mid-single-digit for Solstice from the delay.
BMO maintains an Outperform rating on both stocks. Consensus targets range from $21 to $30 per share. Bond.az analysis suggests the stock is currently overvalued.
Chemours reported Q1 2026 EPS of $0.05, beating estimates of -$0.04. Revenue was $1.4 billion, in line with expectations.
